MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of investments
$213,244K
Proceeds from issuance of
common stock under the...
$141K
Net cash provided by
(used in) investing...
$37,801K
Net cash provided by
financing activities
$141K
Canceled cashflow
$175,443K
Net increase
(decrease) in cash, cash...
-$8,719K
Canceled cashflow
$37,942K
Stock-based compensation
$6,125K
Non-cash lease expense
$3,288K
Accounts payable and
accrued liabilities
$1,634K
Operating lease
liabilities
$1,496K
Depreciation and
amortization
$1,251K
Prepaid expenses and
other assets
-$332K
Purchases of investments
$174,897K
Purchases of property and
equipment
$546K
Net cash used in
operating activities
-$46,661K
Canceled cashflow
$14,126K
Net loss
-$58,197K
Accretion of investments,
net
$2,590K
Back
Back
Cash Flow
source: myfinsight.com
Boundless Bio, Inc. (BOLD)
Boundless Bio, Inc. (BOLD)